metformin has been researched along with fedratinib in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Carayannopoulos, LN; Krishna, G; Liu, L; Liu, M; Ogasawara, K; Palmisano, M; Surapaneni, S; Thomas, M; Wood-Horrall, RN; Xue, Y; Zhou, S | 1 |
2 other study(ies) available for metformin and fedratinib
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Impact of fedratinib on the pharmacokinetics of transporter probe substrates using a cocktail approach.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Cardiotonic Agents; Case-Control Studies; Digoxin; Drug Interactions; Female; Follow-Up Studies; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Neoplasm Proteins; Non-Randomized Controlled Trials as Topic; Organic Anion Transporters; Pyrrolidines; Rosuvastatin Calcium; Sulfonamides; Tissue Distribution; Young Adult | 2021 |